Skip Navigation

European Heart Journal 2000 21(3):198-205; doi:10.1053/euhj.1999.1687
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Elizari, M.V
Right arrow Articles by Cagide, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elizari, M.V
Right arrow Articles by Cagide, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Morbidity and mortality following early administration of amiodarone in acute myocardial infarction

M.V Elizaria,f1, MartínezJ.M b, C Belzitic, M Ciruzzid, R Pérez De La Hozb, A Sinisie, J Carbajalesa, O Scapína, J Garguichevichf, L Girottia and A Cagidec

a Hospital Ramos Mejía, Buenos Aires, Argentina
b Hospital de Clinicas José de San Martín, Buenos Aires, Argentina
c Hospital Italiano, Buenos Aires, Argentina
d Hospital Pirovano, Buenos Aires, Argentina
e Hospital Eva Perón, Pcia. de Buenos Aires, Argentina
f Hospital Español de Rosario, Pcia. de Santa Fe, Argentina

accepted May 12, 1999

Abstract

Aims The objective of this study was to ascertain the effect of intravenous and oral amiodarone on morbidity and mortality in patients during the first hours after the onset of an acute myocardial infarction.

Methods and Results A cohort of 1073 patients admitted to the CCU within 24h of the onset of symptoms of an acute myocardial infarction and heart failure (Killip and Kimball A-B) were randomized to receive amiodarone (n=542) or placebo (n=531) for 6 months. Because of the higher mortality, on an interim analysis, from a ‘high dose’ of amiodarone or placebo (516 patients) the protocol was changed to a ‘low dose’ or placebo (557 patients). Mortality with high doses of amiodarone was 16·30% vs 10·16% in the placebo group (P=0·04), whereas mortality with low doses was 6·61% vs 9·47% in the control group (P=0·20). Several non-fatal adverse effects were observed in 108 and 73 patients treated with amiodarone and placebo, respectively.

Conclusion This study demonstrated that early administration of amiodarone in low doses to patients with an acute myocardial infarction may be used only if life-threatening arrhythmia justify its prescription. Conversely, when given in high doses, it might increase mortality.

Key Words: Amiodarone, mortality, acute myocardial infarction

f1 Correspondence: Marcelo V. Elizari, MD, División Cardiologia, Hospital J.M. Ramos Mejía, Urquiza 609, 1221 Buenos Aires, Argentina.

References

  1. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarction Survival (BASIS). J Am Coll Cardiol. 1990;16:1711–1718[Abstract]
  2. Ceremuzynski L, Kleczar E, Kreminska-Pakula M. Effect of amiodarone on mortality after myocardial infarction: a double blind, placebo-controlled, pilot study. J Am Coll Cardiol. 1992;20:1051–1062
  3. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet. 1997;349:675–682[CrossRef][Web of Science][Medline]
  4. Julian DG, Camm AJ, Frangin G. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 1997;349:667–674[CrossRef][Web of Science][Medline]
  5. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;344:493–498[CrossRef][Web of Science][Medline]
  6. Singh SN, Fletcher RD, Fisher SG. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 1995;333:77–82[Abstract/Free Full Text]
  7. Schwartz A, Shen E, Morady F, Gillespie K, Scheinman M, Chatterjee K. Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia. Am Heart J. 1983;106:848–856[CrossRef][Web of Science][Medline]
  8. Kosinski EJ, Albin JB, Young E, Lewis SM, LeLand S. Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol. 1984;4:565–570[Abstract]
  9. Remme WJ, Kruyssen HACM, Look MP, van Hoogenhuyze DCA, Krauss XH. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function. Am Heart J. 1991;122:96–103[CrossRef][Web of Science][Medline]
  10. Bashir Y, Sneddon JF, Paul VE. A prospective study of the efficacy and safety of adjuvant metroprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function. Am Heart J. 1992;124:1233–1244[CrossRef][Web of Science][Medline]
  11. Lancet. 1997;350:1417–1424[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
J. P. Piccini, J. S. Berger, and C. M. O'Connor
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
Eur. Heart J., May 2, 2009; 30(10): 1245 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
A Y Patwala and D J Wright
Device based treatment of heart failure
Postgrad. Med. J., May 1, 2005; 81(955): 286 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450.
[PDF]

Home page
 DTBHome page
Tackling myocardial infarction
DTB, March 1, 2000; 38(3): 17 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M.M. Scheinman
Amiodarone after acute myocardial infarcation
Eur. Heart J., February 1, 2000; 21(3): 177 - 178.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Elizari, M.V
Right arrow Articles by Cagide, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elizari, M.V
Right arrow Articles by Cagide, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?